Moreover, the subgroup analysis indicated higher expression levels of CILP2 in the more aggressive (quasi-mesenchymal/basal/squamous) subtypes of pancreatic cancer, accompanied by poorer prognoses. Here, CILP2 is linked to familial pancreatic carcinoma.